Optimising treatment for resectable rectal cancer: Is preoperative therapy beneficial?

Drugs and Aging

Volumn 18, Issue 2, 2001, Pages 79-85

  Ngan, Samuel Y K ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; HUMAN; PREOPERATIVE EVALUATION; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; TREATMENT OUTCOME;

ADENOCARCINOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS;

EID: 0035056816     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118020-00001     Document Type: Review

References (42)

1. Radiotherapy treatment for isolated locoregional recurrence of recto-sigmoid carcinoma following definitive surgery
2. Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma
3. Preoperative radiotherapy and chemotherapy for unresectable rectal cancer
4. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: A study of distal intramural spread and of patients' survival
5. A method of reporting radial invasion and surgical clearance of rectal carcinoma
6. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: Histopathological study of lateral tumour spread and surgical excision
7. Patterns of recurrence of rectal cancer after potentially curative surgery
8. The "Holy Plane" of rectal surgery
9. Prolongation of the disease-free interval in surgically treated rectal carcinoma
10. Effective surgical adjuvant therapy for high-risk rectal carcinoma
11. Improving adjuvant therapy for rectal cancer by combining protractedinfusion fluorouracil with radiation therapy after curative surgery
12. Adjuvant therapy for patients with colon and rectal cancer
13. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
14. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
15. A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum: A multicenter trial for the Trans-Tasman Radiation Oncology Group
16. Locally advanced rectal cancer: Surgical complications after infusional chemotherapy and radiation therapy
17. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomised trial and an evaluation of late secondary effects
18. Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a dose-response effect favoring preoperative treatment
19. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin and concurrent radiation therapy for clinically resectable T3 rectal cancer
20. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, sphincter preservation
21. Improved survival with preoperative radiotherapy in resectable rectal cancer Swedish Rectal Cancer Trial
22. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis
23. Preoperative radiation therapy in rectal cancer
24. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: Report of a National Veterans Administration randomised study
25. Preoperative irradiation in operable cancer of the rectum: Report of the Toronto trial
26. The evaluation of low dose preoperative x-ray therapy in the management of operable rectal cancer: Results of a randomly controlled trial
27. Preoperative radiation and surgery for cancer of the rectum
28. Preoperative radiotherapy as adjuvant treatment in rectal cancer: Final results of a randomised study of the European Organisation for Research and Treatment of Cancer (EORTC)
29. A comparison of non-operative vs. preoperative radiotherapy in rectal carcinoma: A 10-year randomised trial
30. Preoperative radiotherapy in operable rectal cancer
31. Preoperative short-term radiation therapy in operable rectal carcinoma: A prospective randomised trial
32. Long-term results of a randomised trial of short-course low-dose adjuvant preoperative radiotherapy for rectal cancer: Reduction in local treatment failure
33. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: Results of a prospective randomised trial
34. Randomised study on preoperative radiotherapy in rectal carcinoma
35. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer
36. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer
37. Preoperative staging of rectal cancer by intrarectal ultrasound
38. Pharmacologic requirements for obtaining sensitisation of human tumour cells in vitro to combined 5-fluorouracil or Ftorafur and x-rays
39. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy
40. Improved survival and reduction in local failure rates after preoperative radiotherapy: Evidence for generalizability of the results of Swedish Rectal Cancer Trial
41. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy
42. Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer: First results of the German multicenter phase III trial